These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35269795)

  • 61. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.
    Menezes MCS; Pestana DVS; Gameiro GR; da Silva LFF; Baron Ė; Rouby JJ; Auler JOC
    Crit Care; 2021 Feb; 25(1):53. PubMed ID: 33557908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection.
    Conte L; Toraldo DM
    Ther Adv Respir Dis; 2020; 14():1753466620937170. PubMed ID: 32600125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
    Balkhi MY
    Mol Immunol; 2021 Jul; 135():268-275. PubMed ID: 33940513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status.
    Hawryłkowicz V; Stasiewicz B; Maciejewska D; Sołek-Pastuszka J; Komorniak N; Skonieczna-Żydecka K; Martynova-Van Kley A; Stachowska E
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination.
    Seong H; Yoon JG; Nham E; Choi YJ; Noh JY; Cheong HJ; Kim WJ; Kim EH; Kim C; Han YH; Lim S; Song JY
    J Transl Med; 2024 Sep; 22(1):827. PubMed ID: 39242525
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Bao R; Hernandez K; Huang L; Luke JJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Tomalka JA; Suthar MS; Deeks SG; Sekaly RP
    Nat Immunol; 2022 Mar; 23(3):360-370. PubMed ID: 35210622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
    James PT; Ali Z; Armitage AE; Bonell A; Cerami C; Drakesmith H; Jobe M; Jones KS; Liew Z; Moore SE; Morales-Berstein F; Nabwera HM; Nadjm B; Pasricha SR; Scheelbeek P; Silver MJ; Teh MR; Prentice AM
    J Nutr; 2021 Jul; 151(7):1854-1878. PubMed ID: 33982105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Probiotics in Medicine: A Long Debate.
    Stavropoulou E; Bezirtzoglou E
    Front Immunol; 2020; 11():2192. PubMed ID: 33072084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.
    Soni B; Kabra R; Singh S
    J Interferon Cytokine Res; 2021 Jul; 41(7):244-257. PubMed ID: 34280026
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2.
    Sarkar A; Harty S; Moeller AH; Klein SL; Erdman SE; Friston KJ; Carmody RN
    Trends Mol Med; 2021 Dec; 27(12):1115-1134. PubMed ID: 34756546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.